Abstract
N-substituted 1,4-dihydropyridines bearing a carboxyl group at the 4-position were synthesized in solvent-free conditions with Cu2+ as the catalyst, imine and β-ketoester as starting materials. The possible mechanism which consists of addition-rearrangement process was proposed and examined by the reaction of isolated product of first addition to β- ketoester.
Keywords: Dihydropyridines, addition-rearrangement, Cu2+-catalyzed, imines, β-ketoester, solvent-free
Letters in Organic Chemistry
Title: Synthesis of New 1, 4-Dihydropyridines by Addition-Rearrangement Process with Imine Derivatives and β-Ketoester as Starting Materials in Solvent-Free Conditions (SUPPORTING INFORMATION)
Volume: 6 Issue: 3
Author(s): Xueming Chen, Xiaoguang Huang, Yunyun Chen, Feng He and Xingshu Li
Affiliation:
Keywords: Dihydropyridines, addition-rearrangement, Cu2+-catalyzed, imines, β-ketoester, solvent-free
Abstract: N-substituted 1,4-dihydropyridines bearing a carboxyl group at the 4-position were synthesized in solvent-free conditions with Cu2+ as the catalyst, imine and β-ketoester as starting materials. The possible mechanism which consists of addition-rearrangement process was proposed and examined by the reaction of isolated product of first addition to β- ketoester.
Export Options
About this article
Cite this article as:
Chen Xueming, Huang Xiaoguang, Chen Yunyun, He Feng and Li Xingshu, Synthesis of New 1, 4-Dihydropyridines by Addition-Rearrangement Process with Imine Derivatives and β-Ketoester as Starting Materials in Solvent-Free Conditions (SUPPORTING INFORMATION), Letters in Organic Chemistry 2009; 6 (3) . https://dx.doi.org/10.2174/157017809787893082
DOI https://dx.doi.org/10.2174/157017809787893082 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Current Pharmaceutical Design Mediterranean Diet in Predementia and Dementia Syndromes
Current Alzheimer Research Diet and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: Molecular Basis of Gastrointestinal Chemical Senses)
Current Pharmaceutical Design Effect of Estrogen Receptor- Alpha Gene Polymorphism (IVS1-397 T>C) on Microvascular Complications of Type 1 Diabetes Mellitus
Current Diabetes Reviews Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies
Recent Patents on DNA & Gene Sequences Bioactive Compounds in Diabetic Cardiomyopathy: Current Approaches and Potential Diagnostic and Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase- II in Vasoactive Peptide- Induced Responses and Vascular Biology
Current Vascular Pharmacology TP Receptor as a Therapeutic Target in Atherosclerosis and Related Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Calcineurin Inhibition and Development: Insights from Research Models
Current Enzyme Inhibition Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Granulocyte Colony-stimulating Factor and Bone Marrow Mononuclear Cells for Stroke Treatment in the Aged Brain
Current Neurovascular Research UPLC-MS for Identification of Quercetin Derivatives in Cuphea glutinosa Cham. & Schltdl (Lythraceae) and Evaluation of Antifungal Potential
Current Pharmaceutical Analysis Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects
Current Pharmaceutical Design Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416
Current Vascular Pharmacology The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets